Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-02

AUTHORS

Carlos Castaneda, Kellen L. Meadows, Roxanne Truax, Michael A. Morse, Scott H. Kaufmann, William P. Petros, Yali Zhu, Paul Statkevich, David L. Cutler, Herbert I. Hurwitz

ABSTRACT

PURPOSE: This phase I study was performed to determine the safety profile, maximum tolerated dose (MTD) and biological activity of lonafarnib (SCH 66336). Single-dose and multi-dose pharmacokinetics were conducted. METHODS: Twenty-one patients with advanced solid tumors were enrolled. Each patient received single-dose administration on day 1, cycle 1 then switched to a twice daily (BID) dosing regimen on days 2-14 of a 28-day cycle; subsequent cycles continued BID dosing on days 1-14. Dose-limiting toxicity (DLT) was assessed during the cycle one; toxicity evaluation was closely monitored throughout the treatment. Radiographic scans were completed to assess tumor response. Blood and urine pharmacokinetics were evaluated on days 1 and 14 in cycle 1. SCH 66336- induced farnesylation inhibition was assessed via conversion of prelamin A to lamin in buccal mucosa. RESULTS: DLT and most common adverse events were diarrhea, fatigue, nausea and anorexia. No grade 3 or 4 hematological toxicities were observed. Nineteen of 21 patients were evaluable for response; short-term stable disease was observed in 5 patients. SCH 66336 systemic exposure increased with dose; however, drug accumulation was higher than projected. Renal excretion of parent drug was negligible. Farnesyl transferase inhibition was detected at the 200 and 300 mg BID doses. CONCLUSION: The MTD and recommended phase II dose is 200 mg BID on days 1-14 of a 28-day dosing regimen. The plasma concentration profile suggests the pharmacokinetics of SCH 66336 is dose and time dependent. Farnesyl transferase target inhibition was observed at doses of lonafarnib recommended for further study. More... »

PAGES

455-463

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-010-1488-5

DOI

http://dx.doi.org/10.1007/s00280-010-1488-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031662375

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20972873


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alkyl and Aryl Transferases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lamin Type A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Maximum Tolerated Dose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mouth Mucosa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nuclear Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Precursors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Instituto Nacional de Enfermedades Neopl\u00e1sicas", 
          "id": "https://www.grid.ac/institutes/grid.419177.d", 
          "name": [
            "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castaneda", 
        "givenName": "Carlos", 
        "id": "sg:person.01030612671.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030612671.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meadows", 
        "givenName": "Kellen L.", 
        "id": "sg:person.014460031617.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014460031617.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Truax", 
        "givenName": "Roxanne", 
        "id": "sg:person.01133626763.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133626763.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morse", 
        "givenName": "Michael A.", 
        "id": "sg:person.013700705377.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic, 55905, Rochester, Minnesota, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaufmann", 
        "givenName": "Scott H.", 
        "id": "sg:person.01342126052.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342126052.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "West Virginia University", 
          "id": "https://www.grid.ac/institutes/grid.268154.c", 
          "name": [
            "Mary Babb Randolph Cancer Center, West Virginia University, 26506, Morgantown, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petros", 
        "givenName": "William P.", 
        "id": "sg:person.0610003000.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610003000.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MSD (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417993.1", 
          "name": [
            "Schering-Plough Research Institute, 07033, Kenilworth, New Jersey, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Yali", 
        "id": "sg:person.01357562202.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357562202.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MSD (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417993.1", 
          "name": [
            "Schering-Plough Research Institute, 07033, Kenilworth, New Jersey, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Statkevich", 
        "givenName": "Paul", 
        "id": "sg:person.01254454060.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254454060.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MSD (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417993.1", 
          "name": [
            "Schering-Plough Research Institute, 07033, Kenilworth, New Jersey, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cutler", 
        "givenName": "David L.", 
        "id": "sg:person.0673106361.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673106361.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hurwitz", 
        "givenName": "Herbert I.", 
        "id": "sg:person.01242177577.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.0403413101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003416326"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.seminoncol.2003.12.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004296390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.270.11.6221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004876600"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m503763200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005457814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m503763200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005457814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.272.22.14459", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009618696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-1262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014070179"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.272.22.14093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015163692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v97.5.1404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015234213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017566383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-03-0412", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019198461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-419x(97)00011-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022401551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1202175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025114095", 
          "https://doi.org/10.1038/sj.onc.1202175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1202175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025114095", 
          "https://doi.org/10.1038/sj.onc.1202175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026802485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026802485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.270.43.25827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031151964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(90)90294-o", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032239893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-008-0536-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033310854", 
          "https://doi.org/10.1007/s00277-008-0536-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-2635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033311674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2005.03.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034672756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.89.14.6403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036302734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.272.25.15591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038597429"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e318187dd57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045077743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e318187dd57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045077743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e318187dd57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045077743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00379-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046295840"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00379-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046295840"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.272.15.10232", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051296996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.4243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052654075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v97.5.1399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052670192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m003469200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052870195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052887834", 
          "https://doi.org/10.1038/sj.onc.1201656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052887834", 
          "https://doi.org/10.1038/sj.onc.1201656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/tx000138v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056296385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/tx000138v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056296385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008313232381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074623638", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074660237", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.4.1167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074754841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074813249", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074829589", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076575034", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1460-2075.1991.tb04979.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077431375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079010052", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083344559", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-02", 
    "datePublishedReg": "2011-02-01", 
    "description": "PURPOSE: This phase I study was performed to determine the safety profile, maximum tolerated dose (MTD) and biological activity of lonafarnib (SCH 66336). Single-dose and multi-dose pharmacokinetics were conducted.\nMETHODS: Twenty-one patients with advanced solid tumors were enrolled. Each patient received single-dose administration on day 1, cycle 1 then switched to a twice daily (BID) dosing regimen on days 2-14 of a 28-day cycle; subsequent cycles continued BID dosing on days 1-14. Dose-limiting toxicity (DLT) was assessed during the cycle one; toxicity evaluation was closely monitored throughout the treatment. Radiographic scans were completed to assess tumor response. Blood and urine pharmacokinetics were evaluated on days 1 and 14 in cycle 1. SCH 66336- induced farnesylation inhibition was assessed via conversion of prelamin A to lamin in buccal mucosa.\nRESULTS: DLT and most common adverse events were diarrhea, fatigue, nausea and anorexia. No grade 3 or 4 hematological toxicities were observed. Nineteen of 21 patients were evaluable for response; short-term stable disease was observed in 5 patients. SCH 66336 systemic exposure increased with dose; however, drug accumulation was higher than projected. Renal excretion of parent drug was negligible. Farnesyl transferase inhibition was detected at the 200 and 300 mg BID doses.\nCONCLUSION: The MTD and recommended phase II dose is 200 mg BID on days 1-14 of a 28-day dosing regimen. The plasma concentration profile suggests the pharmacokinetics of SCH 66336 is dose and time dependent. Farnesyl transferase target inhibition was observed at doses of lonafarnib recommended for further study.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-010-1488-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "67"
      }
    ], 
    "name": "Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors", 
    "pagination": "455-463", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "96d56db3293bcbbccd2d2f6ddbdc772c27602438fa7bc47f099432cd8989a5ac"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20972873"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-010-1488-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031662375"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-010-1488-5", 
      "https://app.dimensions.ai/details/publication/pub.1031662375"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00280-010-1488-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1488-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1488-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1488-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1488-5'


 

This table displays all metadata directly associated to this object as RDF triples.

330 TRIPLES      21 PREDICATES      86 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-010-1488-5 schema:about N05191b9765dd4ee78475cf874a185045
2 N137c52e957634c2aa71bd7bfa5ff50f9
3 N15b698484f9f4a8e8e0b46210af3c30d
4 N1a3acf09fd8f4408aec2d266a6472dd0
5 N396e7a3accf640bdb5d44ad6f3945048
6 N3f18d833cb604efda0d3d03da53e7119
7 N40825fb3e3564c4997b5637443dbef1c
8 N442b7b3b1df347ffb275ab4ed8211782
9 N546c6a8e20e648bc955ad672ae777926
10 N56b61081a7db419b879da5db717692da
11 N642f66ee1f8b4dd590e45509324d09e1
12 N6c8c256c27a945f8b8bd47c89a757d8c
13 N7a737d6fec71427f95f97ecfbc7246c6
14 N9562c216bc434583adb30cf429bd191a
15 N9e8b7ae0868a43ed820a621f0d15a26e
16 Nc18e7a7622474c158c68442e2b60258e
17 Nd1b6746742d243db9c0328fb208af884
18 Nf67181a0128f4b078fe9da43b9248ddc
19 Nf8e31e052c394ab396dd2106456223d5
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author Nd7c43ecc5b1f40589c6e502158cd5f5d
23 schema:citation sg:pub.10.1007/s00277-008-0536-2
24 sg:pub.10.1038/sj.onc.1201656
25 sg:pub.10.1038/sj.onc.1202175
26 https://app.dimensions.ai/details/publication/pub.1074623638
27 https://app.dimensions.ai/details/publication/pub.1074660237
28 https://app.dimensions.ai/details/publication/pub.1074813249
29 https://app.dimensions.ai/details/publication/pub.1074829589
30 https://app.dimensions.ai/details/publication/pub.1076575034
31 https://app.dimensions.ai/details/publication/pub.1079010052
32 https://app.dimensions.ai/details/publication/pub.1083344559
33 https://doi.org/10.1002/cncr.21188
34 https://doi.org/10.1002/cncr.22901
35 https://doi.org/10.1002/j.1460-2075.1991.tb04979.x
36 https://doi.org/10.1016/0092-8674(90)90294-o
37 https://doi.org/10.1016/j.ccr.2005.03.024
38 https://doi.org/10.1016/s0304-419x(97)00011-5
39 https://doi.org/10.1016/s0959-8049(02)00379-9
40 https://doi.org/10.1021/tx000138v
41 https://doi.org/10.1023/a:1008313232381
42 https://doi.org/10.1053/j.seminoncol.2003.12.012
43 https://doi.org/10.1073/pnas.0403413101
44 https://doi.org/10.1073/pnas.89.14.6403
45 https://doi.org/10.1074/jbc.270.11.6221
46 https://doi.org/10.1074/jbc.270.43.25827
47 https://doi.org/10.1074/jbc.272.15.10232
48 https://doi.org/10.1074/jbc.272.22.14093
49 https://doi.org/10.1074/jbc.272.22.14459
50 https://doi.org/10.1074/jbc.272.25.15591
51 https://doi.org/10.1074/jbc.m003469200
52 https://doi.org/10.1074/jbc.m503763200
53 https://doi.org/10.1097/coc.0b013e318187dd57
54 https://doi.org/10.1158/0008-5472.can-05-2635
55 https://doi.org/10.1158/1078-0432.ccr-03-0412
56 https://doi.org/10.1158/1078-0432.ccr-06-1262
57 https://doi.org/10.1182/blood.v97.5.1399
58 https://doi.org/10.1182/blood.v97.5.1404
59 https://doi.org/10.1200/jco.2001.19.4.1167
60 https://doi.org/10.1200/jco.2006.09.4243
61 schema:datePublished 2011-02
62 schema:datePublishedReg 2011-02-01
63 schema:description PURPOSE: This phase I study was performed to determine the safety profile, maximum tolerated dose (MTD) and biological activity of lonafarnib (SCH 66336). Single-dose and multi-dose pharmacokinetics were conducted. METHODS: Twenty-one patients with advanced solid tumors were enrolled. Each patient received single-dose administration on day 1, cycle 1 then switched to a twice daily (BID) dosing regimen on days 2-14 of a 28-day cycle; subsequent cycles continued BID dosing on days 1-14. Dose-limiting toxicity (DLT) was assessed during the cycle one; toxicity evaluation was closely monitored throughout the treatment. Radiographic scans were completed to assess tumor response. Blood and urine pharmacokinetics were evaluated on days 1 and 14 in cycle 1. SCH 66336- induced farnesylation inhibition was assessed via conversion of prelamin A to lamin in buccal mucosa. RESULTS: DLT and most common adverse events were diarrhea, fatigue, nausea and anorexia. No grade 3 or 4 hematological toxicities were observed. Nineteen of 21 patients were evaluable for response; short-term stable disease was observed in 5 patients. SCH 66336 systemic exposure increased with dose; however, drug accumulation was higher than projected. Renal excretion of parent drug was negligible. Farnesyl transferase inhibition was detected at the 200 and 300 mg BID doses. CONCLUSION: The MTD and recommended phase II dose is 200 mg BID on days 1-14 of a 28-day dosing regimen. The plasma concentration profile suggests the pharmacokinetics of SCH 66336 is dose and time dependent. Farnesyl transferase target inhibition was observed at doses of lonafarnib recommended for further study.
64 schema:genre research_article
65 schema:inLanguage en
66 schema:isAccessibleForFree false
67 schema:isPartOf Ncf84c476deaf45a0a99a8a877cf61bca
68 Ned297fa7e631421e8e70c4e5db62f3e2
69 sg:journal.1088364
70 schema:name Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
71 schema:pagination 455-463
72 schema:productId N5e919bce348b4562ae6c9987d6f837ae
73 N6cb0b11525d9450ea1243e9f2a4e4584
74 N8fd41081d2d642dbbb7b56d0418c78b7
75 Nb1c737ea50ad4fe7a7bf94a6d610141f
76 Ndcb407b63da54c9586b2cb9e86a56929
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031662375
78 https://doi.org/10.1007/s00280-010-1488-5
79 schema:sdDatePublished 2019-04-11T00:16
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher Nfcde3b77351a4400bcf684754a4dea68
82 schema:url http://link.springer.com/10.1007%2Fs00280-010-1488-5
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N05191b9765dd4ee78475cf874a185045 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Lamin Type A
88 rdf:type schema:DefinedTerm
89 N0dcea15382914087869f2f7c73ab3dc8 rdf:first sg:person.01242177577.68
90 rdf:rest rdf:nil
91 N137c52e957634c2aa71bd7bfa5ff50f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Pyridines
93 rdf:type schema:DefinedTerm
94 N15b698484f9f4a8e8e0b46210af3c30d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Nuclear Proteins
96 rdf:type schema:DefinedTerm
97 N1a3acf09fd8f4408aec2d266a6472dd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Antineoplastic Agents
99 rdf:type schema:DefinedTerm
100 N1faa03e0d6b4441d8dce23615e9be27b rdf:first sg:person.01357562202.28
101 rdf:rest Nb1f1027737b14eecb71f4ea051f546af
102 N396e7a3accf640bdb5d44ad6f3945048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Area Under Curve
104 rdf:type schema:DefinedTerm
105 N3f18d833cb604efda0d3d03da53e7119 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Piperidines
107 rdf:type schema:DefinedTerm
108 N40825fb3e3564c4997b5637443dbef1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Protein Precursors
110 rdf:type schema:DefinedTerm
111 N442b7b3b1df347ffb275ab4ed8211782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Alkyl and Aryl Transferases
113 rdf:type schema:DefinedTerm
114 N546c6a8e20e648bc955ad672ae777926 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Male
116 rdf:type schema:DefinedTerm
117 N56b61081a7db419b879da5db717692da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Neoplasms
119 rdf:type schema:DefinedTerm
120 N5e919bce348b4562ae6c9987d6f837ae schema:name pubmed_id
121 schema:value 20972873
122 rdf:type schema:PropertyValue
123 N642f66ee1f8b4dd590e45509324d09e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Aged
125 rdf:type schema:DefinedTerm
126 N68ba4800dfa642f0b837a6d565004449 rdf:first sg:person.01133626763.37
127 rdf:rest Nfb999df917d64df6898a59e510c27a49
128 N6c8c256c27a945f8b8bd47c89a757d8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Female
130 rdf:type schema:DefinedTerm
131 N6cb0b11525d9450ea1243e9f2a4e4584 schema:name doi
132 schema:value 10.1007/s00280-010-1488-5
133 rdf:type schema:PropertyValue
134 N7a737d6fec71427f95f97ecfbc7246c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Maximum Tolerated Dose
136 rdf:type schema:DefinedTerm
137 N7b447aea433544a4a6770e35798aad4f rdf:first sg:person.0673106361.44
138 rdf:rest N0dcea15382914087869f2f7c73ab3dc8
139 N8c3ec9ef5cc445d099b241a8169891e5 rdf:first sg:person.014460031617.65
140 rdf:rest N68ba4800dfa642f0b837a6d565004449
141 N8fd41081d2d642dbbb7b56d0418c78b7 schema:name nlm_unique_id
142 schema:value 7806519
143 rdf:type schema:PropertyValue
144 N9562c216bc434583adb30cf429bd191a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Adult
146 rdf:type schema:DefinedTerm
147 N9e8b7ae0868a43ed820a621f0d15a26e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Enzyme Inhibitors
149 rdf:type schema:DefinedTerm
150 Nb1c737ea50ad4fe7a7bf94a6d610141f schema:name dimensions_id
151 schema:value pub.1031662375
152 rdf:type schema:PropertyValue
153 Nb1f1027737b14eecb71f4ea051f546af rdf:first sg:person.01254454060.82
154 rdf:rest N7b447aea433544a4a6770e35798aad4f
155 Nc18e7a7622474c158c68442e2b60258e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Middle Aged
157 rdf:type schema:DefinedTerm
158 Nccbed13a1b884c19b7b94dea2ed87cae rdf:first sg:person.01342126052.27
159 rdf:rest Nd8e25fe272804f998b6b50a41496adf6
160 Ncf84c476deaf45a0a99a8a877cf61bca schema:volumeNumber 67
161 rdf:type schema:PublicationVolume
162 Nd1b6746742d243db9c0328fb208af884 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Mouth Mucosa
164 rdf:type schema:DefinedTerm
165 Nd7c43ecc5b1f40589c6e502158cd5f5d rdf:first sg:person.01030612671.69
166 rdf:rest N8c3ec9ef5cc445d099b241a8169891e5
167 Nd8e25fe272804f998b6b50a41496adf6 rdf:first sg:person.0610003000.44
168 rdf:rest N1faa03e0d6b4441d8dce23615e9be27b
169 Ndcb407b63da54c9586b2cb9e86a56929 schema:name readcube_id
170 schema:value 96d56db3293bcbbccd2d2f6ddbdc772c27602438fa7bc47f099432cd8989a5ac
171 rdf:type schema:PropertyValue
172 Ned297fa7e631421e8e70c4e5db62f3e2 schema:issueNumber 2
173 rdf:type schema:PublicationIssue
174 Nf67181a0128f4b078fe9da43b9248ddc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Treatment Outcome
176 rdf:type schema:DefinedTerm
177 Nf8e31e052c394ab396dd2106456223d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Humans
179 rdf:type schema:DefinedTerm
180 Nfb999df917d64df6898a59e510c27a49 rdf:first sg:person.013700705377.06
181 rdf:rest Nccbed13a1b884c19b7b94dea2ed87cae
182 Nfcde3b77351a4400bcf684754a4dea68 schema:name Springer Nature - SN SciGraph project
183 rdf:type schema:Organization
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
188 schema:name Clinical Sciences
189 rdf:type schema:DefinedTerm
190 sg:journal.1088364 schema:issn 0344-5704
191 1432-0843
192 schema:name Cancer Chemotherapy and Pharmacology
193 rdf:type schema:Periodical
194 sg:person.01030612671.69 schema:affiliation https://www.grid.ac/institutes/grid.419177.d
195 schema:familyName Castaneda
196 schema:givenName Carlos
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030612671.69
198 rdf:type schema:Person
199 sg:person.01133626763.37 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
200 schema:familyName Truax
201 schema:givenName Roxanne
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133626763.37
203 rdf:type schema:Person
204 sg:person.01242177577.68 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
205 schema:familyName Hurwitz
206 schema:givenName Herbert I.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68
208 rdf:type schema:Person
209 sg:person.01254454060.82 schema:affiliation https://www.grid.ac/institutes/grid.417993.1
210 schema:familyName Statkevich
211 schema:givenName Paul
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254454060.82
213 rdf:type schema:Person
214 sg:person.01342126052.27 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
215 schema:familyName Kaufmann
216 schema:givenName Scott H.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342126052.27
218 rdf:type schema:Person
219 sg:person.01357562202.28 schema:affiliation https://www.grid.ac/institutes/grid.417993.1
220 schema:familyName Zhu
221 schema:givenName Yali
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357562202.28
223 rdf:type schema:Person
224 sg:person.013700705377.06 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
225 schema:familyName Morse
226 schema:givenName Michael A.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06
228 rdf:type schema:Person
229 sg:person.014460031617.65 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
230 schema:familyName Meadows
231 schema:givenName Kellen L.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014460031617.65
233 rdf:type schema:Person
234 sg:person.0610003000.44 schema:affiliation https://www.grid.ac/institutes/grid.268154.c
235 schema:familyName Petros
236 schema:givenName William P.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610003000.44
238 rdf:type schema:Person
239 sg:person.0673106361.44 schema:affiliation https://www.grid.ac/institutes/grid.417993.1
240 schema:familyName Cutler
241 schema:givenName David L.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673106361.44
243 rdf:type schema:Person
244 sg:pub.10.1007/s00277-008-0536-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033310854
245 https://doi.org/10.1007/s00277-008-0536-2
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/sj.onc.1201656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052887834
248 https://doi.org/10.1038/sj.onc.1201656
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/sj.onc.1202175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025114095
251 https://doi.org/10.1038/sj.onc.1202175
252 rdf:type schema:CreativeWork
253 https://app.dimensions.ai/details/publication/pub.1074623638 schema:CreativeWork
254 https://app.dimensions.ai/details/publication/pub.1074660237 schema:CreativeWork
255 https://app.dimensions.ai/details/publication/pub.1074813249 schema:CreativeWork
256 https://app.dimensions.ai/details/publication/pub.1074829589 schema:CreativeWork
257 https://app.dimensions.ai/details/publication/pub.1076575034 schema:CreativeWork
258 https://app.dimensions.ai/details/publication/pub.1079010052 schema:CreativeWork
259 https://app.dimensions.ai/details/publication/pub.1083344559 schema:CreativeWork
260 https://doi.org/10.1002/cncr.21188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026802485
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1002/cncr.22901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017566383
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1002/j.1460-2075.1991.tb04979.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1077431375
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1016/0092-8674(90)90294-o schema:sameAs https://app.dimensions.ai/details/publication/pub.1032239893
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1016/j.ccr.2005.03.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034672756
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1016/s0304-419x(97)00011-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022401551
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1016/s0959-8049(02)00379-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046295840
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1021/tx000138v schema:sameAs https://app.dimensions.ai/details/publication/pub.1056296385
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1023/a:1008313232381 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303084
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1053/j.seminoncol.2003.12.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004296390
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1073/pnas.0403413101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003416326
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1073/pnas.89.14.6403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036302734
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1074/jbc.270.11.6221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004876600
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1074/jbc.270.43.25827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031151964
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1074/jbc.272.15.10232 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051296996
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1074/jbc.272.22.14093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015163692
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1074/jbc.272.22.14459 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009618696
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1074/jbc.272.25.15591 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038597429
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1074/jbc.m003469200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052870195
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1074/jbc.m503763200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005457814
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1097/coc.0b013e318187dd57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045077743
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1158/0008-5472.can-05-2635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033311674
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1158/1078-0432.ccr-03-0412 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019198461
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1158/1078-0432.ccr-06-1262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014070179
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1182/blood.v97.5.1399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052670192
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1182/blood.v97.5.1404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015234213
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1200/jco.2001.19.4.1167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074754841
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1200/jco.2006.09.4243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052654075
315 rdf:type schema:CreativeWork
316 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
317 schema:name Duke University Medical Center, 27710, Durham, North Carolina, USA
318 rdf:type schema:Organization
319 https://www.grid.ac/institutes/grid.268154.c schema:alternateName West Virginia University
320 schema:name Mary Babb Randolph Cancer Center, West Virginia University, 26506, Morgantown, WV, USA
321 rdf:type schema:Organization
322 https://www.grid.ac/institutes/grid.417993.1 schema:alternateName MSD (United States)
323 schema:name Schering-Plough Research Institute, 07033, Kenilworth, New Jersey, USA
324 rdf:type schema:Organization
325 https://www.grid.ac/institutes/grid.419177.d schema:alternateName Instituto Nacional de Enfermedades Neoplásicas
326 schema:name Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
327 rdf:type schema:Organization
328 https://www.grid.ac/institutes/grid.66875.3a schema:alternateName Mayo Clinic
329 schema:name Mayo Clinic, 55905, Rochester, Minnesota, USA
330 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...